{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:54:32Z","timestamp":1790891672383,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ucl.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:55:32Z","timestamp":1787691332000},"page":"625-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Surgery in Locally Advanced and Oligometastatic Bladder Cancer"],"prefix":"10.1016","volume":"53","author":[{"given":"Navid","family":"Roessler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte W.","family":"Vetterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ucl.2026.06.003_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ucl.2026.06.003_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 Guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci"},{"issue":"10","key":"10.1016\/j.ucl.2026.06.003_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ucl.2026.06.003_bib8","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa2309863","article-title":"Nivolumab plus gemcitabine-cisplatin in advanced urothelial carcinoma","volume":"389","author":"van der Heijden","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","article-title":"Factors involved in cancer metastasis: a better understanding to \"seed and soil\" hypothesis","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2017.09.030","article-title":"The role of surgery in metastatic bladder cancer: a systematic review","volume":"73","author":"Abufaraj","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.euf.2025.03.011","article-title":"Metastasis-directed therapy in the management of urothelial carcinoma: a systematic review and meta-analysis","volume":"11","author":"Miszczyk","year":"2025","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.eururo.2023.05.005","article-title":"Definition and diagnosis of oligometastatic bladder cancer: a Delphi consensus Study endorsed by the European Association of urology, European Society for radiotherapy and oncology, and European Society of Medical oncology Genitourinary Faculty","volume":"84","author":"Bamias","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2026.06.003_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.euros.2023.08.003","article-title":"Defining oligometastatic bladder cancer: a systematic review","volume":"55","author":"Bamias","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.eururo.2023.06.003","article-title":"Oligometastatic bladder cancer: defining a novel entity","volume":"84","author":"Labaki","year":"2023","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.ucl.2026.06.003_bib17","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00432-022-03926-1","article-title":"Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study","volume":"148","author":"Choi","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12894-020-00733-z","article-title":"Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients","volume":"20","author":"Hamid","year":"2020","journal-title":"BMC Urol"},{"issue":"29","key":"10.1016\/j.ucl.2026.06.003_bib19","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.2016.66.7352","article-title":"Efficacy of high-intensity local treatment for metastatic urothelial carcinoma of the bladder: a propensity score-weighted analysis from the national cancer data base","volume":"34","author":"Seisen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2026.06.003_bib20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10147-015-0839-y","article-title":"Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery","volume":"20","author":"Urakami","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bju.16319","article-title":"The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer","volume":"134","author":"von Deimling","year":"2024","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2026.06.003_bib23","doi-asserted-by":"crossref","first-page":"59.e51","DOI":"10.1016\/j.urolonc.2015.08.012","article-title":"Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: the M.D. Anderson cancer center experience","volume":"34","author":"Ho","year":"2016","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2015.07.085","article-title":"A multi-institutional analysis of outcomes of patients with clinically node positive urothelial bladder cancer treated with induction chemotherapy and radical cystectomy","volume":"195","author":"Zargar-Shoshtari","year":"2016","journal-title":"J Urol"},{"issue":"22","key":"10.1016\/j.ucl.2026.06.003_bib25","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1200\/JCO.2016.67.5033","article-title":"Comparative effectiveness of treatment strategies for bladder cancer with clinical evidence of regional lymph node involvement","volume":"34","author":"Galsky","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.urology.2013.08.082","article-title":"Induction chemotherapy followed by surgery in node positive bladder cancer","volume":"83","author":"Meijer","year":"2014","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2026.06.003_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2021.07.018","article-title":"High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival","volume":"40","author":"Sood","year":"2022","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.urology.2008.07.035","article-title":"Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy","volume":"73","author":"Kassouf","year":"2009","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.juro.2012.06.018","article-title":"Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?","volume":"188","author":"Mertens","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.06.003_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.euros.2023.02.014","article-title":"Carboplatin induction chemotherapy in clinically lymph node-positive bladder cancer","volume":"51","author":"von Deimling","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10147-011-0350-z","article-title":"Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?","volume":"18","author":"Bekku","year":"2013","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejso.2008.07.001","article-title":"Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only","volume":"35","author":"de Vries","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clgc.2014.06.003","article-title":"Postchemotherapy lymphadenectomy in patients with metastatic urothelial carcinoma: long-term efficacy and implications for trial design","volume":"13","author":"Necchi","year":"2015","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.ucl.2026.06.003_bib34","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/01.ju.0000067601.29966.4a","article-title":"Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?","volume":"169","author":"Sweeney","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.06.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2026.02.019","article-title":"Radiation therapy combined with immunotherapy before radical cystectomy in locally advanced bladder cancer: a prospective, single-arm, multicenter, phase 2 trial (RACE-IT)","author":"Schmid","year":"2026","journal-title":"Eur Urol Oncol"},{"issue":"27","key":"10.1016\/j.ucl.2026.06.003_bib36","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1200\/JCO.23.00725","article-title":"Bladder-sparing treatment with radical dose radiotherapy is an effective alternative to radical cystectomy in patients with clinically node-positive nonmetastatic bladder cancer","volume":"41","author":"Swinton","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2026.06.003_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.eururo.2025.05.015","article-title":"Consolidative surgery for advanced urothelial carcinoma following induction enfortumab vedotin and\/or immune checkpoint inhibitor therapy: a multicenter analysis","volume":"88","author":"Roberson","year":"2025","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0090-4295(82)90462-9","article-title":"Long-term results following thoracotomy for metastatic bladder cancer","volume":"20","author":"Cowles","year":"1982","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib39","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.eururo.2007.02.052","article-title":"Impact of multimodal treatment on survival in patients with metastatic urothelial cancer","volume":"52","author":"Abe","year":"2007","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib40","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.juro.2013.11.004","article-title":"Outcome of metastasectomy for urothelial carcinoma: a multi-institutional retrospective study in Japan","volume":"191","author":"Abe","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2026.06.003_bib41","first-page":"1","article-title":"Outcomes of surgical therapy for local recurrence and oligometastatic urothelial carcinoma of the bladder: 20 years of experience in a tertiary center","author":"Al-Nader","year":"2024","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000099823.60465.e6","article-title":"Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience","volume":"171","author":"Siefker-Radtke","year":"2004","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0090-4295(00)00867-0","article-title":"Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial","volume":"57","author":"Otto","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2026.06.003_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2023.03.035","article-title":"Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era-Is it time for a new paradigm shift? A systematic review and meta-analysis","volume":"187","author":"Peters","year":"2023","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2026.06.003_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamaoncol.2018.5543","article-title":"Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial","volume":"5","author":"Bex","year":"2019","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.ucl.2026.06.003_bib46","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1803675","article-title":"Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma","volume":"379","author":"M\u00e9jean","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ucl.2026.06.003_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.euf.2016.12.003","article-title":"Impact of baseline characteristics on the survival benefit of high-intensity local treatment in metastatic urothelial carcinoma of the bladder","volume":"4","author":"Vetterlein","year":"2018","journal-title":"Eur Urol Focus"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21037\/tau-24-586","article-title":"Efficacy of cystectomy in single-site oligometastatic bladder cancer: a surveillance, epidemiology, and end results (SEER) study of 1,381 patients","volume":"14","author":"Ji","year":"2025","journal-title":"Transl Androl Urol"},{"issue":"3","key":"10.1016\/j.ucl.2026.06.003_bib49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MOU.0000000000001170","article-title":"Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology","volume":"34","author":"Calleris","year":"2024","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.ucl.2026.06.003_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41467-020-20493-6","article-title":"Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer","volume":"12","author":"Vandekerkhove","year":"2021","journal-title":"Nat Commun"},{"issue":"19","key":"10.1016\/j.ucl.2026.06.003_bib51","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa2408154","article-title":"Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer","volume":"391","author":"Powles","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432600056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009401432600056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:59:26Z","timestamp":1790888366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009401432600056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S009401432600056X"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2026.06.003","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Surgery in Locally Advanced and Oligometastatic Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}